ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
Funders

Uncle Kory Foundation

Foundation · El Segundo, California, United States

Visit website
0
Open now
$586K
Given in 2025
$50K
Typical grant
Invitation only
Takes applications
$888K
Assets

Open now

Nothing open right now.

Where the money went

2025 tax return

$25K
Research, 1 grant
$475K
Universities, 11 grants
  • City of Hope$50K

    Targeting non-coding rna pseudouridine modification for glioblastoma therapy

  • Cornell University$50K

    To fund project "regulation of myeloid cells by fatty acid metabolism in irradiated glioblastoma." 2nd year renewal

  • Duke University$50K

    Sirpiglenastat for treating glioblastoma

  • Regents University of California Los Angeles$50K

    Characterizing ptprz1 mechanism in cancer as a therapeutic target, 3rd year funding

  • The UCLA Foundation$50K

    Hapten-modified neoantigens as immune targets for glioblastoma treatment

All 16 grants
RecipientPurposeAmount
The Mark Foundation for Cancer ResearchNew York, NYFoundation gift for the gbm initiative$25K
City of HopeDuarte, CATargeting non-coding rna pseudouridine modification for glioblastoma therapy$50K
Cornell UniversityIthaca, NYTo fund project "regulation of myeloid cells by fatty acid metabolism in irradiated glioblastoma." 2nd year renewal$50K
Duke UniversityDurham, NCSirpiglenastat for treating glioblastoma$50K
Regents University of California Los AngelesLos Angeles, CACharacterizing ptprz1 mechanism in cancer as a therapeutic target, 3rd year funding$50K
The UCLA FoundationLos Angeles, CAHapten-modified neoantigens as immune targets for glioblastoma treatment$50K
The University of Texas MD Anderson Cancer CenterHouston, TXProject fp00009152 - Repurposing migraine treatments for dipg - 5th year funding$50K
The University of Texas MD Anderson Cancer CenterHouston, TXAutophagy inhibition to sensitize medulloblastoma to enhance nk cell immunotherapy$50K
University of Alabama at BirminghamBirmingham, ALTargeting recurrent glioblastoma cells using collagen-binding il-12 and il-7$50K
University of California San FranciscoSan Francisco, CADefining neural dependent vulnerabilities in gbm radiation sensitization using functional genomics$50K
University of Southern CaliforniaLos Angeles, CAThe role of gaba transaminase in medulloblastoma local recurrence and its potential as a therapeutic target in medulloblastoma metastasis 3rd year funding$50K
Duke UniversityDurham, NC"the care-bear proposal." 2nd year renewal; portion transferred to university of colorado. Remaining funds reimbursed and then allocated to university of colorado regents.$34K
Regents of the University of ColoradoAurora, CO"the care-bear proposal." 2nd year renewal$16K
Brain Tumor Epidemiology ConsortiumHinsdale, ILCharacterizing ptprz1 mechanism in cancer as a therapeutic target, 3rd year funding$5K
Central Brain Tumor Registry of the United StatesHinsdale, ILGeneral support$5K
The UCLA FoundationLos Angeles, CATo support the work of dr. Cloughesy and dr. Liau at the brain tumor center of ucla.$579

Crossref funder 100019451 · EIN 46-4485313 · ROR 02p6wqg36